Cardiotoxicity in breast cancer patients after radiotherapy – modern methods of minimizing the dose to the heart and dilemmas of choosing critical cardiac structures for monitoring dose distribution
Journal Title: OncoReview - Year 2016, Vol 6, Issue 3
Abstract
Radiotherapy in breast cancer patients is an important component of multidisciplinary treatment. It reduces the risk of local recurrence and mortality from breast cancer. However, it can lead to secondary effects due to the presence of the heart within the irradiation field. Adjuvant radiation therapy for breast cancer increases the risk of coronary artery disease, myocardial infarction and cardiovascular death. It is important to determine the optimal treatment to minimize cardiotoxicity. Modern radiotherapy techniques may reduce radiation-induced cardiac toxicity, but it is necessary to determine the most sensitive structures within the heart, tolerance doses, and methods for early detection and monitoring of adverse effects.
Authors and Affiliations
Katarzyna Pudełek, Jacek Pudełek, Sergiusz Nawrocki
Keywords
Related Articles
- EP ID EP80364
- DOI -
- Views 177
- Downloads 0
Results of a multi-centre survey concerning the treatment of hormone-dependent breast cancer in Poland in 2009–2013
In order to present a reliable picture of hormone-dependent breast cancer treatment in Poland, an on-line survey has been conducted in 19 oncology centres. As a result, data on the treatment of 486 patients have been obt...
Dystres i depresja u chorych na nowotwory - diagnostyka i leczenie
Choroba nowotworowa burzy dotychczasowy porządek wewnętrzny i zewnętrzny pacjenta, który wcześniej nie przeżywał takiej sytuacji. Najczęściej odczuwanymi negatywnymi emocjami w sytuacji diagnozy onkologicznej są: lęk, pr...
Targeted therapies in neuroendocrine neoplasms
The primary treatment of gastrointestinal neuroendocrine tumors is surgery, and its extent depends on the clinical stage of cancer. In advanced disease medical therapy is used. One possible form of treatment is biologica...
Original vs generic drugs in treatment of chronic myeloid leukaemia
The beginning of the twenty-first century saw a breakthrough in haematology, oncology and general medicine driven by the introduction of imatinib (Glivec) to the treatment of chronic myeloid leukaemia. For the first time...
Depression in patients with cancer. Diagnosis and treatment in clinical practice
Comorbidity between depression and cancer is a common condition. It depends on many variables such as cancer location or phase of the illness, but as a rule this situation should not be neglected. The reasons for providi...